Angle plc (AGL) Ordinary 10p
1.00p
(1.90%)
- Add to watchlist
- Create an alert
- This stock can be held in a
1.00p
(1.90%)
1.00p
(1.90%)
52.50p
52.75p
75.50p
£73.90 million
52.50p
51.00p
38.00p
n/a
0.00p (0.00%) Previous:
0.00p
168,739
n/a
5,000
Performance
Not available for this stock.
Fundamental data
| Year ending: | 30/04/2018 | 30/04/2017 |
|---|---|---|
| Revenue (£m) | 0.63 | 0.50 |
| Profit before tax (£m) | (8.93) | (7.41) |
| Adjusted EPS (p): | (10.09) | (8.95) |
| P/E ratio | n/a | n/a |
| PEG | n/a | n/a |
| EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: British pound
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Open an easy to manage, low cost dealing account in less than 5 minutes
Deal shares from just £11.95 per trade online, and as low as £5.95 per trade for active traders.
More about the Fund and Share AccountImportant Documents
There are no documents available for this stock.
Broker forecasts
-
Strong Sell
(0 of 1) -
Sell
(0 of 1) -
Neutral
(1 of 1) -
Buy
(0 of 1) -
Strong Buy
(0 of 1)
This is not a recommendation, it represents the consensus view of a basket of brokers. If fewer than 5 brokers it may not be a valid consensus. HL might not concur and takes no responsibility.
Full broker forecasts-
Angle completes enrolment in Parsortix breast cancer study
7 March 2019 09:35
-
Angle client demonstrates new use for 'Parsortix' system
25 February 2019 10:51
-
Angle's 'Parsortix' used in new groundbreaking cancer research
11 February 2019 11:35
-
Holding(s) in Company
11 March 2019 07:00
-
ENROLMENT COMPLETE FOR FDA CLINICAL STUDY
7 March 2019 07:00
-
FIRST SUBJECTS ENROLLED IN OVARIAN CANCER STUDY
28 February 2019 07:00
| Time / date Time | Buy / sell Type | Volume | Price | Value |
|---|
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled ‘N/A’.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.